| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |